Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway
The original release is unavailable here.
Lexaria Bioscience Corp. on 6ix
Story so far
Earlier from Lexaria Bioscience
- Lexaria Attending the BIO International Convention, as Part of a Broader Business Development Program
- Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7
- Lexaria Bioscience Releases Second Episode of Investor Video Series
- Lexaria Updates Progress on Human Study #7
- Lexaria Bioscience Launches Ongoing Investor Video Series to Expand Shareholder Communications
Later from Lexaria Bioscience
- Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule
- Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule
- Lexaria Updates Business Development
- Lexaria Announces Effective Date for Reverse Stock Split
- Lexaria Enters a Material Transfer Agreement With PegBio
Follow Lexaria Bioscience into a list and get an email when it puts out news.
Follow Lexaria Bioscience